US Stocks
/
Innate Pharma S.A. ADS Share Price

Innate Pharma S.A. ADS Share Price

NASDAQ: IPHA
$1.54
-$0.06 (-3.75%) Last updated on 08 Oct, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Innate Pharma S.A. ADS Stock Performance

Open
$1.54
Prev. Close
$1.60
Circuit Range
N/A
Day Range
$1.54 - $1.54
Year Range
$1.21 - $2.60
Volume
325
Average Traded
$1.54

Innate Pharma S.A. ADS Share Price Today

As of 9 October 2026, Innate Pharma S.A. ADS's share price is $1.54. The stock opened at $1.54, compared to its previous close of $1.60. During today's trading session, Innate Pharma S.A. ADS's share price traded between $1.54 and $1.54, with an average price of $1.54. Over the past 52 weeks, the stock has recorded a high of $2.60 and a low of $1.21. In terms of performance, Innate Pharma S.A. ADS's share price has risen by 4.76% over the last six months and is down 21.63% on a year-on-year basis.

Innate Pharma S.A. ADS Share Price Chart

$1.54$1.54
L
Show Current Price
H

Innate Pharma S.A. ADS Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Innate Pharma S.A. ADS Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.58
$1.54
-6.95%
Sep 2026
$2.13
$1.66
-27.41%
Aug 2026
$1.73
$2.28
+30.29%
Jul 2026
$1.81
$1.75
-3.31%
Jun 2026
$1.80
$1.81
+3.72%
May 2026
$1.44
$1.75
+18.71%
Apr 2026
$1.37
$1.47
+16.67%
Mar 2026
$1.61
$1.26
-25.88%
Feb 2026
$1.84
$1.70
-9.09%
Jan 2026
$1.82
$1.87
+5.06%
Dec 2025
$1.95
$1.78
-9.18%
Nov 2025
$1.93
$1.96
-0.25%

IPHA Share Price FAQs

What is Innate Pharma S.A. ADS share price today?

chevron-up
Innate Pharma S.A. ADS share price today is $1.54 as on October 8, 2026 at 1:25 am IST.

What is the 52 week high and 52 week low of Innate Pharma S.A. ADS stock?

chevron-up
The 52 week high of Innate Pharma S.A. ADS stock is $2.60, while the 52 week low is $1.21 as of 8 Oct '26.

What is the 5 year returns of IPHA?

chevron-up
The 5 year returns of IPHA is -73.45% as on 8 Oct '26.

What is the high & low stock price of IPHA today?

chevron-up
IPHA stock price hit a high of $1.54 and low of $1.54 as of 8 Oct '26.

Can I buy IPHA shares in India?

chevron-up
Yes. You can buy IPHA in India by opening an international trading account.